nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Melatonin—CYP19A1—osteoporosis	0.00601	0.521	CrCbGaD
Midodrine—Melatonin—ESR1—osteoporosis	0.00553	0.479	CrCbGaD
Midodrine—Feeling abnormal—Etidronic acid—osteoporosis	0.00238	0.00241	CcSEcCtD
Midodrine—Nervous system disorder—Raloxifene—osteoporosis	0.00237	0.0024	CcSEcCtD
Midodrine—Chills—Pamidronate—osteoporosis	0.00237	0.0024	CcSEcCtD
Midodrine—Urethral disorder—Zoledronate—osteoporosis	0.00236	0.00239	CcSEcCtD
Midodrine—Gastrointestinal pain—Etidronic acid—osteoporosis	0.00236	0.00239	CcSEcCtD
Midodrine—Skin disorder—Raloxifene—osteoporosis	0.00235	0.00238	CcSEcCtD
Midodrine—Nervous system disorder—Ibandronate—osteoporosis	0.00235	0.00238	CcSEcCtD
Midodrine—Back pain—Risedronate—osteoporosis	0.00234	0.00237	CcSEcCtD
Midodrine—Skin disorder—Ibandronate—osteoporosis	0.00233	0.00235	CcSEcCtD
Midodrine—Muscle spasms—Risedronate—osteoporosis	0.00232	0.00235	CcSEcCtD
Midodrine—Nausea—Ergocalciferol—osteoporosis	0.00231	0.00233	CcSEcCtD
Midodrine—Abdominal pain—Etidronic acid—osteoporosis	0.00228	0.00231	CcSEcCtD
Midodrine—Skin disorder—Calcitriol—osteoporosis	0.00228	0.0023	CcSEcCtD
Midodrine—Insomnia—Estropipate—osteoporosis	0.00226	0.00228	CcSEcCtD
Midodrine—Tension—Pamidronate—osteoporosis	0.00226	0.00228	CcSEcCtD
Midodrine—Paraesthesia—Estropipate—osteoporosis	0.00224	0.00227	CcSEcCtD
Midodrine—Flushing—Zoledronate—osteoporosis	0.00224	0.00226	CcSEcCtD
Midodrine—Cardiac disorder—Zoledronate—osteoporosis	0.00224	0.00226	CcSEcCtD
Midodrine—Nervousness—Pamidronate—osteoporosis	0.00223	0.00226	CcSEcCtD
Midodrine—Abdominal discomfort—Estradiol—osteoporosis	0.00223	0.00225	CcSEcCtD
Midodrine—Back pain—Pamidronate—osteoporosis	0.00222	0.00225	CcSEcCtD
Midodrine—Somnolence—Estropipate—osteoporosis	0.00222	0.00225	CcSEcCtD
Midodrine—Muscle spasms—Pamidronate—osteoporosis	0.00221	0.00224	CcSEcCtD
Midodrine—Dyspepsia—Estropipate—osteoporosis	0.0022	0.00222	CcSEcCtD
Midodrine—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.0022	0.00222	CcSEcCtD
Midodrine—Angiopathy—Zoledronate—osteoporosis	0.00219	0.00221	CcSEcCtD
Midodrine—Insomnia—Raloxifene—osteoporosis	0.00219	0.00221	CcSEcCtD
Midodrine—Insomnia—Ibandronate—osteoporosis	0.00217	0.00219	CcSEcCtD
Midodrine—Dyspepsia—Alendronate—osteoporosis	0.00216	0.00219	CcSEcCtD
Midodrine—Chills—Zoledronate—osteoporosis	0.00216	0.00219	CcSEcCtD
Midodrine—Gastrointestinal disorder—Estropipate—osteoporosis	0.00216	0.00218	CcSEcCtD
Midodrine—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.00216	0.00218	CcSEcCtD
Midodrine—Paraesthesia—Ibandronate—osteoporosis	0.00215	0.00218	CcSEcCtD
Midodrine—Pollakiuria—Estradiol—osteoporosis	0.00214	0.00217	CcSEcCtD
Midodrine—Pain—Estropipate—osteoporosis	0.00214	0.00216	CcSEcCtD
Midodrine—Dyspepsia—Raloxifene—osteoporosis	0.00213	0.00215	CcSEcCtD
Midodrine—Insomnia—Calcitriol—osteoporosis	0.00212	0.00214	CcSEcCtD
Midodrine—Mental disorder—Zoledronate—osteoporosis	0.00211	0.00214	CcSEcCtD
Midodrine—Agitation—Pamidronate—osteoporosis	0.00211	0.00214	CcSEcCtD
Midodrine—Dyspepsia—Ibandronate—osteoporosis	0.00211	0.00213	CcSEcCtD
Midodrine—Angiopathy—Conjugated Estrogens—osteoporosis	0.00211	0.00213	CcSEcCtD
Midodrine—Anxiety—Ethinyl Estradiol—osteoporosis	0.0021	0.00213	CcSEcCtD
Midodrine—Pain—Alendronate—osteoporosis	0.0021	0.00213	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.0021	0.00212	CcSEcCtD
Midodrine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00209	0.00211	CcSEcCtD
Midodrine—Hypertension—Risedronate—osteoporosis	0.00209	0.00211	CcSEcCtD
Midodrine—Somnolence—Calcitriol—osteoporosis	0.00208	0.00211	CcSEcCtD
Midodrine—Pain—Raloxifene—osteoporosis	0.00207	0.00209	CcSEcCtD
Midodrine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.00207	0.00209	CcSEcCtD
Midodrine—Anxiety—Risedronate—osteoporosis	0.00205	0.00208	CcSEcCtD
Midodrine—Pain—Ibandronate—osteoporosis	0.00205	0.00207	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.00204	0.00207	CcSEcCtD
Midodrine—Pruritus—Etidronic acid—osteoporosis	0.00204	0.00207	CcSEcCtD
Midodrine—Gastrointestinal pain—Estropipate—osteoporosis	0.00204	0.00207	CcSEcCtD
Midodrine—Mental disorder—Conjugated Estrogens—osteoporosis	0.00203	0.00206	CcSEcCtD
Midodrine—Back pain—Zoledronate—osteoporosis	0.00203	0.00205	CcSEcCtD
Midodrine—Feeling abnormal—Alendronate—osteoporosis	0.00203	0.00205	CcSEcCtD
Midodrine—Muscle spasms—Zoledronate—osteoporosis	0.00202	0.00204	CcSEcCtD
Midodrine—Dry mouth—Risedronate—osteoporosis	0.00201	0.00204	CcSEcCtD
Midodrine—Gastrointestinal pain—Alendronate—osteoporosis	0.00201	0.00203	CcSEcCtD
Midodrine—Pain—Calcitriol—osteoporosis	0.002	0.00203	CcSEcCtD
Midodrine—Flatulence—Conjugated Estrogens—osteoporosis	0.00199	0.00202	CcSEcCtD
Midodrine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.00198	0.00201	CcSEcCtD
Midodrine—Hypertension—Pamidronate—osteoporosis	0.00198	0.00201	CcSEcCtD
Midodrine—Tension—Conjugated Estrogens—osteoporosis	0.00198	0.00201	CcSEcCtD
Midodrine—Gastrointestinal pain—Raloxifene—osteoporosis	0.00198	0.002	CcSEcCtD
Midodrine—Abdominal pain—Estropipate—osteoporosis	0.00197	0.002	CcSEcCtD
Midodrine—Feeling abnormal—Ibandronate—osteoporosis	0.00197	0.002	CcSEcCtD
Midodrine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00197	0.00199	CcSEcCtD
Midodrine—Nervousness—Conjugated Estrogens—osteoporosis	0.00196	0.00199	CcSEcCtD
Midodrine—Hepatobiliary disease—Estradiol—osteoporosis	0.00196	0.00198	CcSEcCtD
Midodrine—Gastrointestinal pain—Ibandronate—osteoporosis	0.00196	0.00198	CcSEcCtD
Midodrine—Back pain—Conjugated Estrogens—osteoporosis	0.00196	0.00198	CcSEcCtD
Midodrine—Anxiety—Pamidronate—osteoporosis	0.00195	0.00197	CcSEcCtD
Midodrine—Abdominal pain—Alendronate—osteoporosis	0.00194	0.00197	CcSEcCtD
Midodrine—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00194	0.00197	CcSEcCtD
Midodrine—Nervous system disorder—Risedronate—osteoporosis	0.00194	0.00196	CcSEcCtD
Midodrine—Agitation—Zoledronate—osteoporosis	0.00193	0.00195	CcSEcCtD
Midodrine—Skin disorder—Risedronate—osteoporosis	0.00192	0.00194	CcSEcCtD
Midodrine—Gastrointestinal pain—Calcitriol—osteoporosis	0.00192	0.00194	CcSEcCtD
Midodrine—Abdominal pain—Raloxifene—osteoporosis	0.00191	0.00193	CcSEcCtD
Midodrine—Abdominal pain—Ibandronate—osteoporosis	0.00189	0.00191	CcSEcCtD
Midodrine—Confusional state—Pamidronate—osteoporosis	0.00189	0.00191	CcSEcCtD
Midodrine—Abdominal pain—Calcitriol—osteoporosis	0.00185	0.00187	CcSEcCtD
Midodrine—Nervous system disorder—Pamidronate—osteoporosis	0.00184	0.00186	CcSEcCtD
Midodrine—Urinary tract disorder—Estradiol—osteoporosis	0.00184	0.00186	CcSEcCtD
Midodrine—Tachycardia—Pamidronate—osteoporosis	0.00183	0.00185	CcSEcCtD
Midodrine—Urethral disorder—Estradiol—osteoporosis	0.00182	0.00184	CcSEcCtD
Midodrine—Rash—Etidronic acid—osteoporosis	0.00182	0.00184	CcSEcCtD
Midodrine—Dermatitis—Etidronic acid—osteoporosis	0.00182	0.00184	CcSEcCtD
Midodrine—Hypertension—Zoledronate—osteoporosis	0.00181	0.00183	CcSEcCtD
Midodrine—Headache—Etidronic acid—osteoporosis	0.00181	0.00183	CcSEcCtD
Midodrine—Asthenia—Estropipate—osteoporosis	0.00179	0.00181	CcSEcCtD
Midodrine—Insomnia—Risedronate—osteoporosis	0.00178	0.00181	CcSEcCtD
Midodrine—Anxiety—Zoledronate—osteoporosis	0.00178	0.0018	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.00177	0.0018	CcSEcCtD
Midodrine—Paraesthesia—Risedronate—osteoporosis	0.00177	0.00179	CcSEcCtD
Midodrine—Pruritus—Estropipate—osteoporosis	0.00177	0.00179	CcSEcCtD
Midodrine—Asthenia—Alendronate—osteoporosis	0.00176	0.00179	CcSEcCtD
Midodrine—Dyspnoea—Risedronate—osteoporosis	0.00176	0.00178	CcSEcCtD
Midodrine—Erythema multiforme—Estradiol—osteoporosis	0.00176	0.00178	CcSEcCtD
Midodrine—Dry mouth—Zoledronate—osteoporosis	0.00175	0.00177	CcSEcCtD
Midodrine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.00175	0.00177	CcSEcCtD
Midodrine—Pruritus—Alendronate—osteoporosis	0.00174	0.00176	CcSEcCtD
Midodrine—Dyspepsia—Risedronate—osteoporosis	0.00174	0.00176	CcSEcCtD
Midodrine—Confusional state—Zoledronate—osteoporosis	0.00173	0.00175	CcSEcCtD
Midodrine—Cardiac disorder—Estradiol—osteoporosis	0.00172	0.00174	CcSEcCtD
Midodrine—Flushing—Estradiol—osteoporosis	0.00172	0.00174	CcSEcCtD
Midodrine—Asthenia—Ibandronate—osteoporosis	0.00172	0.00174	CcSEcCtD
Midodrine—Anxiety—Conjugated Estrogens—osteoporosis	0.00172	0.00174	CcSEcCtD
Midodrine—Nausea—Etidronic acid—osteoporosis	0.00171	0.00173	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.00171	0.00173	CcSEcCtD
Midodrine—Gastrointestinal disorder—Risedronate—osteoporosis	0.0017	0.00172	CcSEcCtD
Midodrine—Insomnia—Pamidronate—osteoporosis	0.0017	0.00172	CcSEcCtD
Midodrine—Pruritus—Ibandronate—osteoporosis	0.00169	0.00171	CcSEcCtD
Midodrine—Pain—Risedronate—osteoporosis	0.00169	0.00171	CcSEcCtD
Midodrine—Angiopathy—Estradiol—osteoporosis	0.00169	0.00171	CcSEcCtD
Midodrine—Paraesthesia—Pamidronate—osteoporosis	0.00168	0.0017	CcSEcCtD
Midodrine—Asthenia—Calcitriol—osteoporosis	0.00168	0.0017	CcSEcCtD
Midodrine—Nervous system disorder—Zoledronate—osteoporosis	0.00168	0.0017	CcSEcCtD
Midodrine—Dyspnoea—Pamidronate—osteoporosis	0.00167	0.00169	CcSEcCtD
Midodrine—Tachycardia—Zoledronate—osteoporosis	0.00167	0.00169	CcSEcCtD
Midodrine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00167	0.00169	CcSEcCtD
Midodrine—Chills—Estradiol—osteoporosis	0.00167	0.00169	CcSEcCtD
Midodrine—Somnolence—Pamidronate—osteoporosis	0.00167	0.00169	CcSEcCtD
Midodrine—Skin disorder—Zoledronate—osteoporosis	0.00166	0.00168	CcSEcCtD
Midodrine—Pruritus—Calcitriol—osteoporosis	0.00166	0.00168	CcSEcCtD
Midodrine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.00165	0.00167	CcSEcCtD
Midodrine—Dyspepsia—Pamidronate—osteoporosis	0.00165	0.00167	CcSEcCtD
Midodrine—Dizziness—Estropipate—osteoporosis	0.00165	0.00167	CcSEcCtD
Midodrine—Mental disorder—Estradiol—osteoporosis	0.00163	0.00165	CcSEcCtD
Midodrine—Dizziness—Alendronate—osteoporosis	0.00163	0.00165	CcSEcCtD
Midodrine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.00162	0.00164	CcSEcCtD
Midodrine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.00162	0.00164	CcSEcCtD
Midodrine—Gastrointestinal pain—Risedronate—osteoporosis	0.00161	0.00163	CcSEcCtD
Midodrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.00161	0.00163	CcSEcCtD
Midodrine—Pain—Pamidronate—osteoporosis	0.0016	0.00162	CcSEcCtD
Midodrine—Skin disorder—Conjugated Estrogens—osteoporosis	0.0016	0.00162	CcSEcCtD
Midodrine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.0016	0.00162	CcSEcCtD
Midodrine—Dizziness—Raloxifene—osteoporosis	0.0016	0.00162	CcSEcCtD
Midodrine—Flatulence—Estradiol—osteoporosis	0.00159	0.00161	CcSEcCtD
Midodrine—Tension—Estradiol—osteoporosis	0.00159	0.00161	CcSEcCtD
Midodrine—Dizziness—Ibandronate—osteoporosis	0.00158	0.0016	CcSEcCtD
Midodrine—Rash—Estropipate—osteoporosis	0.00157	0.00159	CcSEcCtD
Midodrine—Dermatitis—Estropipate—osteoporosis	0.00157	0.00159	CcSEcCtD
Midodrine—Nervousness—Estradiol—osteoporosis	0.00157	0.00159	CcSEcCtD
Midodrine—Back pain—Estradiol—osteoporosis	0.00156	0.00158	CcSEcCtD
Midodrine—Headache—Estropipate—osteoporosis	0.00156	0.00158	CcSEcCtD
Midodrine—Abdominal pain—Risedronate—osteoporosis	0.00156	0.00158	CcSEcCtD
Midodrine—Muscle spasms—Estradiol—osteoporosis	0.00156	0.00157	CcSEcCtD
Midodrine—Rash—Alendronate—osteoporosis	0.00155	0.00157	CcSEcCtD
Midodrine—Insomnia—Zoledronate—osteoporosis	0.00155	0.00157	CcSEcCtD
Midodrine—Dermatitis—Alendronate—osteoporosis	0.00155	0.00157	CcSEcCtD
Midodrine—Feeling abnormal—Pamidronate—osteoporosis	0.00155	0.00156	CcSEcCtD
Midodrine—Headache—Alendronate—osteoporosis	0.00154	0.00156	CcSEcCtD
Midodrine—Paraesthesia—Zoledronate—osteoporosis	0.00154	0.00156	CcSEcCtD
Midodrine—Gastrointestinal pain—Pamidronate—osteoporosis	0.00153	0.00155	CcSEcCtD
Midodrine—Dyspnoea—Zoledronate—osteoporosis	0.00153	0.00155	CcSEcCtD
Midodrine—Rash—Raloxifene—osteoporosis	0.00152	0.00154	CcSEcCtD
Midodrine—Dermatitis—Raloxifene—osteoporosis	0.00152	0.00154	CcSEcCtD
Midodrine—Somnolence—Zoledronate—osteoporosis	0.00152	0.00154	CcSEcCtD
Midodrine—Headache—Raloxifene—osteoporosis	0.00152	0.00153	CcSEcCtD
Midodrine—Rash—Ibandronate—osteoporosis	0.00151	0.00153	CcSEcCtD
Midodrine—Dermatitis—Ibandronate—osteoporosis	0.00151	0.00153	CcSEcCtD
Midodrine—Dyspepsia—Zoledronate—osteoporosis	0.00151	0.00153	CcSEcCtD
Midodrine—Headache—Ibandronate—osteoporosis	0.0015	0.00152	CcSEcCtD
Midodrine—Insomnia—Conjugated Estrogens—osteoporosis	0.00149	0.00151	CcSEcCtD
Midodrine—Agitation—Estradiol—osteoporosis	0.00149	0.0015	CcSEcCtD
Midodrine—Nausea—Estropipate—osteoporosis	0.00148	0.0015	CcSEcCtD
Midodrine—Abdominal pain—Pamidronate—osteoporosis	0.00148	0.0015	CcSEcCtD
Midodrine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00148	0.0015	CcSEcCtD
Midodrine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.00148	0.0015	CcSEcCtD
Midodrine—Rash—Calcitriol—osteoporosis	0.00148	0.0015	CcSEcCtD
Midodrine—Dermatitis—Calcitriol—osteoporosis	0.00148	0.00149	CcSEcCtD
Midodrine—Dyspnoea—Conjugated Estrogens—osteoporosis	0.00147	0.00149	CcSEcCtD
Midodrine—Headache—Calcitriol—osteoporosis	0.00147	0.00149	CcSEcCtD
Midodrine—Somnolence—Conjugated Estrogens—osteoporosis	0.00147	0.00148	CcSEcCtD
Midodrine—Pain—Zoledronate—osteoporosis	0.00147	0.00148	CcSEcCtD
Midodrine—Nausea—Alendronate—osteoporosis	0.00146	0.00148	CcSEcCtD
Midodrine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.00145	0.00147	CcSEcCtD
Midodrine—Asthenia—Ethinyl Estradiol—osteoporosis	0.00145	0.00147	CcSEcCtD
Midodrine—Nausea—Raloxifene—osteoporosis	0.00144	0.00145	CcSEcCtD
Midodrine—Pruritus—Ethinyl Estradiol—osteoporosis	0.00143	0.00145	CcSEcCtD
Midodrine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00142	0.00144	CcSEcCtD
Midodrine—Nausea—Ibandronate—osteoporosis	0.00142	0.00144	CcSEcCtD
Midodrine—Asthenia—Risedronate—osteoporosis	0.00142	0.00143	CcSEcCtD
Midodrine—Feeling abnormal—Zoledronate—osteoporosis	0.00141	0.00143	CcSEcCtD
Midodrine—Pain—Conjugated Estrogens—osteoporosis	0.00141	0.00143	CcSEcCtD
Midodrine—Gastrointestinal pain—Zoledronate—osteoporosis	0.0014	0.00142	CcSEcCtD
Midodrine—Hypertension—Estradiol—osteoporosis	0.0014	0.00141	CcSEcCtD
Midodrine—Pruritus—Risedronate—osteoporosis	0.0014	0.00141	CcSEcCtD
Midodrine—Nausea—Calcitriol—osteoporosis	0.00139	0.00141	CcSEcCtD
Midodrine—Anxiety—Estradiol—osteoporosis	0.00137	0.00139	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.00137	0.00138	CcSEcCtD
Midodrine—Abdominal pain—Zoledronate—osteoporosis	0.00135	0.00137	CcSEcCtD
Midodrine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00135	0.00136	CcSEcCtD
Midodrine—Dry mouth—Estradiol—osteoporosis	0.00135	0.00136	CcSEcCtD
Midodrine—Asthenia—Pamidronate—osteoporosis	0.00135	0.00136	CcSEcCtD
Midodrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.00134	0.00135	CcSEcCtD
Midodrine—Confusional state—Estradiol—osteoporosis	0.00133	0.00135	CcSEcCtD
Midodrine—Pruritus—Pamidronate—osteoporosis	0.00133	0.00134	CcSEcCtD
Midodrine—Dizziness—Risedronate—osteoporosis	0.0013	0.00132	CcSEcCtD
Midodrine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.0013	0.00132	CcSEcCtD
Midodrine—Nervous system disorder—Estradiol—osteoporosis	0.00129	0.00131	CcSEcCtD
Midodrine—Tachycardia—Estradiol—osteoporosis	0.00129	0.0013	CcSEcCtD
Midodrine—Skin disorder—Estradiol—osteoporosis	0.00128	0.0013	CcSEcCtD
Midodrine—Rash—Ethinyl Estradiol—osteoporosis	0.00128	0.00129	CcSEcCtD
Midodrine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00127	0.00129	CcSEcCtD
Midodrine—Headache—Ethinyl Estradiol—osteoporosis	0.00127	0.00128	CcSEcCtD
Midodrine—Rash—Risedronate—osteoporosis	0.00124	0.00126	CcSEcCtD
Midodrine—Dermatitis—Risedronate—osteoporosis	0.00124	0.00126	CcSEcCtD
Midodrine—Dizziness—Pamidronate—osteoporosis	0.00124	0.00125	CcSEcCtD
Midodrine—Headache—Risedronate—osteoporosis	0.00124	0.00125	CcSEcCtD
Midodrine—Asthenia—Zoledronate—osteoporosis	0.00123	0.00124	CcSEcCtD
Midodrine—Pruritus—Zoledronate—osteoporosis	0.00121	0.00123	CcSEcCtD
Midodrine—Nausea—Ethinyl Estradiol—osteoporosis	0.0012	0.00122	CcSEcCtD
Midodrine—Insomnia—Estradiol—osteoporosis	0.00119	0.00121	CcSEcCtD
Midodrine—Paraesthesia—Estradiol—osteoporosis	0.00119	0.0012	CcSEcCtD
Midodrine—Asthenia—Conjugated Estrogens—osteoporosis	0.00118	0.0012	CcSEcCtD
Midodrine—Rash—Pamidronate—osteoporosis	0.00118	0.0012	CcSEcCtD
Midodrine—Dermatitis—Pamidronate—osteoporosis	0.00118	0.0012	CcSEcCtD
Midodrine—Dyspnoea—Estradiol—osteoporosis	0.00118	0.00119	CcSEcCtD
Midodrine—Headache—Pamidronate—osteoporosis	0.00118	0.00119	CcSEcCtD
Midodrine—Somnolence—Estradiol—osteoporosis	0.00117	0.00119	CcSEcCtD
Midodrine—Nausea—Risedronate—osteoporosis	0.00117	0.00119	CcSEcCtD
Midodrine—Pruritus—Conjugated Estrogens—osteoporosis	0.00117	0.00118	CcSEcCtD
Midodrine—Dyspepsia—Estradiol—osteoporosis	0.00116	0.00118	CcSEcCtD
Midodrine—Gastrointestinal disorder—Estradiol—osteoporosis	0.00114	0.00115	CcSEcCtD
Midodrine—Dizziness—Zoledronate—osteoporosis	0.00113	0.00115	CcSEcCtD
Midodrine—Pain—Estradiol—osteoporosis	0.00113	0.00114	CcSEcCtD
Midodrine—Nausea—Pamidronate—osteoporosis	0.00111	0.00113	CcSEcCtD
Midodrine—Dizziness—Conjugated Estrogens—osteoporosis	0.00109	0.0011	CcSEcCtD
Midodrine—Feeling abnormal—Estradiol—osteoporosis	0.00109	0.0011	CcSEcCtD
Midodrine—Rash—Zoledronate—osteoporosis	0.00108	0.00109	CcSEcCtD
Midodrine—Gastrointestinal pain—Estradiol—osteoporosis	0.00108	0.00109	CcSEcCtD
Midodrine—Dermatitis—Zoledronate—osteoporosis	0.00108	0.00109	CcSEcCtD
Midodrine—Headache—Zoledronate—osteoporosis	0.00107	0.00109	CcSEcCtD
Midodrine—Abdominal pain—Estradiol—osteoporosis	0.00104	0.00106	CcSEcCtD
Midodrine—Rash—Conjugated Estrogens—osteoporosis	0.00104	0.00105	CcSEcCtD
Midodrine—Dermatitis—Conjugated Estrogens—osteoporosis	0.00104	0.00105	CcSEcCtD
Midodrine—Headache—Conjugated Estrogens—osteoporosis	0.00103	0.00105	CcSEcCtD
Midodrine—Nausea—Zoledronate—osteoporosis	0.00102	0.00103	CcSEcCtD
Midodrine—Nausea—Conjugated Estrogens—osteoporosis	0.00098	0.000991	CcSEcCtD
Midodrine—Asthenia—Estradiol—osteoporosis	0.000947	0.000958	CcSEcCtD
Midodrine—Pruritus—Estradiol—osteoporosis	0.000934	0.000945	CcSEcCtD
Midodrine—Dizziness—Estradiol—osteoporosis	0.000873	0.000883	CcSEcCtD
Midodrine—Rash—Estradiol—osteoporosis	0.000833	0.000842	CcSEcCtD
Midodrine—Dermatitis—Estradiol—osteoporosis	0.000832	0.000841	CcSEcCtD
Midodrine—Headache—Estradiol—osteoporosis	0.000827	0.000837	CcSEcCtD
Midodrine—Nausea—Estradiol—osteoporosis	0.000784	0.000793	CcSEcCtD
